The Netherlands is home to 2,900 innovative Life Sciences businesses, including 420 biopharmaceutical companies, and the European Medicines Agency, making it one of the most concentrated Life Sciences and Health clusters in the world. About 770 clinical trials are currently active in the Netherlands and the country boasts a competitive international business climate which is reflected by its status as the sixth-largest EY economy, a major global exporter and importer of goods and a Forbes ranking as the third best country for doing business. Together with a very strong scientific background it makes the Dutch industry a major European player with great economic- and societal impact.
The Dutch Life Sciences conference is hosted by organisations and companies whose mission is to help realize the further development and growth of the Dutch life sciences industry. The 15th edition of the Dutch Life Sciences conference will take place at the Leiden Bio Science Park on November 28th, 2019. The conference inspires and promote an open exchange of information including trends and developments in the industry.
The programme consists of plenary sessions and parallel sessions, an investors forum, active networking possibilities and an information market. In addition the winner of the Venture Challenge Award will be announced.
Note: the organisation keeps the right to make changes to the programme at any time.
08:00 CxO breakfast meeting: for CEOs, CFOs, COOs and CBOs active in the life sciences sector.
08:00 Investors forum part 1 – breakfast session
08:45 Registration and information desk open
08:45 Exhibition and Startup corner
09:30 Plenary morning programme
10:00 Live Broadcasting BNR newsradio: BNR´s Big Five van de biowetenschappen (in Dutch)
11:15 Parallel morning sessions
12:30 Investors forum part 2 – lunch session
13:30 Parallel afternoon sessions
15:30 Closing plenary programme
Do you have any questions?
Feel free to contact us.